Related Experiment Video
Updated: Jul 31, 2025

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer
Ramesh Singh1, Huan Meng1, Tao Shen1
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
Abstract:
Castration-resistant prostate cancer (CRPC) poses a major clinical challenge with the androgen receptor (AR) remaining to be a critical oncogenic player. Several lines of evidence indicate that AR induces a distinct transcriptional program after androgen deprivation in CRPCs. However, the mechanism triggering AR binding to a distinct set of genomic loci in CRPC and how it promotes CRPC development remain unclear. We demonstrate here that atypical ubiquitination of AR mediated by an E3 ubiquitin ligase TRAF4 plays an important role in this process. TRAF4 is highly expressed in CRPCs and promotes CRPC development. It mediates K27-linked ubiquitination at the C-terminal tail of AR and increases its association with the pioneer factor FOXA1. Consequently, AR binds to a distinct set of genomic loci enriched with FOXA1- and HOXB13-binding motifs to drive different transcriptional programs including an olfactory transduction pathway. Through the surprising upregulation of olfactory receptor gene transcription, TRAF4 increases intracellular cAMP levels and boosts E2F transcription factor activity to promote cell proliferation under androgen deprivation conditions. Altogether, these findings reveal a posttranslational mechanism driving AR-regulated transcriptional reprogramming to provide survival advantages for prostate cancer cells under castration conditions.
Insights
TRAF4 E3 ligase drives castration-resistant prostate cancer (CRPC) by altering androgen receptor (AR) binding. This atypical ubiquitination promotes AR
Area of Science:
- Molecular Oncology
- Cancer Biology
- Ubiquitination Signaling
Background:
- Castration-resistant prostate cancer (CRPC) remains a clinical challenge, with the androgen receptor (AR) as a key driver.
- AR induces distinct transcriptional programs in CRPC after androgen deprivation, but the underlying mechanisms are unclear.
- Understanding AR's genomic binding and its role in CRPC development is crucial for therapeutic strategies.
Purpose of the Study:
- To elucidate the mechanism by which AR binds to distinct genomic loci in CRPC.
- To investigate the role of atypical ubiquitination in AR-mediated transcriptional reprogramming in CRPC.
- To identify novel therapeutic targets for castration-resistant prostate cancer.
Main Methods:
- Investigated the role of E3 ubiquitin ligase TRAF4 in CRPC development.
- Analyzed AR ubiquitination status, specifically K27-linked ubiquitination, and its effect on AR-FOXA1 interaction.
- Examined AR binding to genomic loci and subsequent transcriptional changes, including olfactory transduction pathways.
Main Results:
- TRAF4 is highly expressed in CRPC and promotes tumor development.
- TRAF4 mediates K27-linked ubiquitination of AR, enhancing its association with FOXA1.
- TRAF4-mediated AR reprogramming drives olfactory receptor gene transcription, increasing cAMP and E2F activity, promoting proliferation in castration conditions.
Conclusions:
- Atypical ubiquitination of AR by TRAF4 is a key posttranslational mechanism driving AR-regulated transcriptional reprogramming in CRPC.
- TRAF4 facilitates AR binding to specific genomic sites, promoting cell survival and proliferation under androgen deprivation.
- Targeting TRAF4-mediated ubiquitination may offer a novel therapeutic strategy for castration-resistant prostate cancer.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway
GPCR Desensitization